Immunotherapy and Systemic Therapy in Metastatic/Recurrent Endometrial and Cervical Cancers
Abstract
Despite advances in the treatment of gynaecological malignancies, both recurrent endometrial and cervical cancers when not amenable to localised therapy (surgery or radiotherapy), remain incurable with limited prognosis and effective treatment options. Chemotherapy remains the standard of care for women with metastatic endometrial or cervical cancers. The addition of bevacizumab to first-line chemotherapy for metastatic cervical cancer patients...
Paper Details
Title
Immunotherapy and Systemic Therapy in Metastatic/Recurrent Endometrial and Cervical Cancers
Published Date
Sep 1, 2021
Journal
Volume
33
Issue
9
Pages
608 - 615
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History